External quality assessment of patient HLA-B*57:01 testing prior to abacavir prescription

International Journal of Immunogenetics

Volumn 41, Issue 4, 2014, Pages 277-280

  Darke, C ^a   Corbin, S A ^a  

^a Welsh Blood Service   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; HLA B57 ANTIGEN; 2',3' DIDEOXYNUCLEOSIDE DERIVATIVE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; HLA B ANTIGEN; HLA-B*57:01 ANTIGEN;

ALLELE; ARTICLE; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; DRUG SCREENING; EXTERNAL QUALITY ASSESSMENT; HLA TYPING; HUMAN; OLIGONUCLEOTIDE PROBE; PRESCRIPTION; PRIORITY JOURNAL; QUALITY CONTROL; GENETIC SCREENING; GENETICS; HISTOCOMPATIBILITY TEST; IMMUNOLOGY; POLYMERASE CHAIN REACTION; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STANDARDS; STATISTICS AND NUMERICAL DATA;

ALLELES; ANTI-HIV AGENTS; DIDEOXYNUCLEOSIDES; DRUG HYPERSENSITIVITY; GENETIC TESTING; HISTOCOMPATIBILITY TESTING; HLA-B ANTIGENS; HUMANS; POLYMERASE CHAIN REACTION; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84903899332     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/iji.12122     Document Type: Article

References (16)

1. Asboe, D., Aitken, C., Boffito, M., Booth, C., Cane, P., Fakoya, A. et al. (2012) British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals 2011. HIV Medicine, 13, 1.
2. Downing, J., Guttridge, M.G., Thompson, J. & Darke, C. (2004) Five-locus HLA typing of hematopoietic stem cell donor volunteers using PCR sequence specific primers. Genetic Testing, 8, 301.
3. Gonzalez-Galarza, F.F., Christmas, S., Middleton, D. & Jones, A.R. (2011) Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Research, 39, D913.
4. Gonzalez-Galarza, F.F., Mack, S.J., Hollenbach, J., Fernandez-Vina, M., Setterholm, M., Kempenich, J. et al. (2013) 16th IHIW: extending the number of resources and bioinformatics analysis for the investigation of HLA rare alleles. International Journal of Immunogenetics, 40, 60.
5. Guttridge, M.G., Thompson, J., Street, J. & Darke, C. (1999) Identification, sequencing and serology of HLA-B*3527. Tissue Antigens, 53, 383.
6. Hammond, E., Almeida, C.A., Mamotte, C., Nolan, D., Phillips, E., Schollaardt, T.A. et al. (2007) External quality assessment of HLA-B*5701 reporting: an international multicentre survey. Antiviral Therapy, 12, 1027.
7. Hetherington, S., Hughes, A.R., Mosteller, M., Shortino, D., Baker, K.L., Spreen, W. et al. (2002) Genetic variations in HLA-B region and hypersensitivity reactions to abacavir. Lancet, 359, 1121.
8. Mallal, S., Nolan, D., Witt, C., Masel, G., Martin, A.M., Moore, C. et al. (2002) Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet, 359, 727.
9. Marsh, S.G., Albert, E.D., Bodmer, W.F., Bontrop, R.E., Dupont, B., Erlich, H.A. et al. (2010) Nomenclature for factors of the HLA system, 2010. Tissue Antigens, 75, 291.
10. Martin, M.A., Klein, T.E., Dong, B.J., Pirmohamed, M., Haas, D.W. & Kroetz, D.L. (2012) Clinical pharmacogenetics implementation consortium guidelines for HLA-B genotype and abacavir dosing. Clinical Pharmacology & Therapeutics, 91, 734.
11. Munderi, P., Snowden, W.B., Walker, A.S., Kityo, C., Mosteller, M., Kabuye, G. et al. (2011) Distribution of HLA-B alleles in a Ugandan HIV-infected adult population: NORA pharmacogenetic substudy of DART. Tropical Medicine & International Health, 16, 200.
12. Rauch, A., Nolan, D., Martin, A., McKinnon, E., Almeida, C. & Mallal, S. (2006) Prospective genetic screening decreases the incidence of abacavir hypersensitivity reactions in the Western Australian HIV cohort study. Clinical Infectious Diseases, 43, 99.
13. Robinson, J., Mistry, K., McWilliam, H., Lopez, R., Parham, P. & Marsh, S.G.E. (2011) The IMGT/HLA database. Nucleic Acids Research, 39(Suppl. 1), D1171.
14. Saag, M., Balu, R., Phillips, E., Brachman, P., Martorell, C., Burman, W. et al. (2008) High sensitivity of human leukocyte antigen-B*5701 as a marker of immunologically confirmed abacavir hypersensitivity in white and black patients. Clinical Infectious Diseases, 46, 1111.
15. Sanchez-Mazas, A., Vidan-Jeras, B., Nunes, J.M., Fischer, G., Little, A.M., Bekmane, U. et al. (2012) Strategies to work with HLA data in human populations for histocompatibility, clinical transplantation, epidemiology and population genetics: HLA-NET methodological recommendations. International Journal of Immunogenetics, 39, 459.
16. Stocchi, L., Cascella, R., Zampatti, S., Pirazzoli, A., Novelli, G. & Giardina, E. (2012) The pharmacogenomic HLA biomarker associated to adverse abacavir reactions: comparative analysis of different genotyping methods. Current Genomics, 13, 314.